» Articles » PMID: 26161170

Risk Factors for Unsuccessful Tuberculosis Treatment Outcome (failure, Default and Death) in Public Health Institutions, Eastern Ethiopia

Overview
Journal Pan Afr Med J
Date 2015 Jul 11
PMID 26161170
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Unsuccessful TB treatment outcome is a serious public health concern. It is compelling to identify, and deal with factors determining unsuccessful treatment outcome. Therefore, study was aimed to determine pattern of unsuccessful TB treatment outcome and associated factors in eastern Ethiopia.

Methods: A case control study was used. Cases were records of TB patients registered as defaulter, dead and/or treatment failure where as controls were those cured or treatment complete. Multivariate logistic regression models were used to derive adjusted odds ratios (OR) at 95% CI to examine the relationship between the unsuccessful TB treatment outcome and patients' characteristics.

Results: A total of 990 sample size (330 cases and 660 controls) were included. Among cases (n = 330), majority 212(64.2%) were because of death, 100(30.3%) defaulters and 18(5.5%) were treatment failure. Lack of contact person(OR = 1.37; 95% CI 1.14-2.9, P, .024), sputum smear negative treatment category at initiation of treatment (OR = 1.8; 95% CI 1.3-5.5,P, .028), smear positive sputum test result at 2(nd) month after initiation treatment (OR = 14; 95% CI 5.5-36, P,0.001) and HIV positive status (OR = 2.5; 95% CI 1.34-5.7, P, 0.01) were independently associated with increased risk of unsuccessful TB treatment outcome.

Conclusion: Death was the major cause of unsuccessful TB treatment outcome. TB patients do not have contact person, sputum smear negative treatment category at initiation of treatment, smear positive on 2(nd) month after treatment initiation and HIV positive were factors significantly associated unsuccessful treatment outcome. TB patients with sputum smear negative treatment category, HIV positive and smear positive on 2(nd) nd month of treatment initiation need strict follow up throughout DOTs period.

Citing Articles

Trends, prevalence, and determinants of unfavorable tuberculosis treatment outcomes among adult patients in Northeast Ethiopia: The race to achieve a 90 % treatment success rate by 2025.

Kitaw T, Baylie A, Getie A, Haile R Glob Epidemiol. 2025; 9:100189.

PMID: 40041024 PMC: 11876761. DOI: 10.1016/j.gloepi.2025.100189.


Determinants of unsuccessful tuberculosis treatment outcome in Southwest Ethiopia regional state public hospitals, 2022: a multi-center case control study.

Berihe Hiluf S, Abera A, Bahiru M, Kassie B Front Public Health. 2024; 12:1406211.

PMID: 39502821 PMC: 11534863. DOI: 10.3389/fpubh.2024.1406211.


Treatment Outcomes of Single-Dose Liposomal Amphotericin B-Treated Visceral Leishmaniasis Patients and Factors Affecting Outcome in Bihar, India.

Siddiqui N, Ansari M, Sinha S, Pal B, Singh A, Singh S Am J Trop Med Hyg. 2024; 111(6):1198-1205.

PMID: 39378874 PMC: 11619493. DOI: 10.4269/ajtmh.23-0640.


Evaluating tuberculosis treatment outcomes in Haiti from 2018 to 2019: A competing risk analysis.

Raphael N, Garraud P, Roelens M, Alfred J, Richard M, Estill J IJID Reg. 2024; 11:100350.

PMID: 38577553 PMC: 10993134. DOI: 10.1016/j.ijregi.2024.03.005.


Nutritional status and treatment outcomes of tuberculosis in Mizan Tepi University Teaching Hospital, a five -year retrospective study.

Simieneh A, Gashaneh S, Dereje R PLoS One. 2024; 19(2):e0298244.

PMID: 38359007 PMC: 10868852. DOI: 10.1371/journal.pone.0298244.


References
1.
Lorent N, Sebatunzi O, Mukeshimana G, van den Ende J, Clerinx J . Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study. PLoS One. 2011; 6(5):e19566. PMC: 3097195. DOI: 10.1371/journal.pone.0019566. View

2.
Jianzhao H, van den Hof S, Lin X, Yubang Q, Jinglong H, van der Werf M . Risk factors for non-cure among new sputum smear positive tuberculosis patients treated in tuberculosis dispensaries in Yunnan, China. BMC Health Serv Res. 2011; 11:97. PMC: 3112400. DOI: 10.1186/1472-6963-11-97. View

3.
Yen Y, Yen M, Shih H, Deng C . Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan. Trans R Soc Trop Med Hyg. 2012; 106(5):303-8. DOI: 10.1016/j.trstmh.2012.01.011. View

4.
Yone E, Kuaban C, Kengne A . HIV testing, HIV status and outcomes of treatment for tuberculosis in a major diagnosis and treatment centre in Yaounde, Cameroon: a retrospective cohort study. BMC Infect Dis. 2012; 12:190. PMC: 3482584. DOI: 10.1186/1471-2334-12-190. View

5.
Shaweno D, Worku A . Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in Southern Ethiopia: a retrospective cohort study. BMC Res Notes. 2012; 5:682. PMC: 3585495. DOI: 10.1186/1756-0500-5-682. View